2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups

2017/10/27 by Ingrid E Lundberg, Ingrid E. Lundberg, Anna Tjärnlund +58 · 26 citations
Medicine · #Inflammatory Myopathies and Dermatomyositis #Autoimmune and Inflammatory Disorders Research #Parkinson's Disease and Spinal Disorders

paper · doi:10.1136/annrheumdis-2017-211468

Cited by

• Autologous haematopoietic stem cell transplantation for rheumatic diseases: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee
• Bench to bedside review of myositis autoantibodies. [europepmc]
• New Myositis Classification Criteria-What We Have Learned Since Bohan and Peter. [europepmc]
• Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status. [europepmc]
• Classification and management of adult inflammatory myopathies. [europepmc]
• Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools. [europepmc]
• Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective. [europepmc]
• MRI of skeletal muscles in patients with idiopathic inflammatory myopathies: characteristic findings and diagnostic performance in dermatomyositis. [europepmc]
• Comparison of Three Immunoassays for the Detection of Myositis Specific Antibodies. [europepmc]
• Biomarkers in Inflammatory Myopathies-An Expanded Definition. [europepmc]
• Demographic and clinical predictors of progression and mortality in connective tissue disease-associated interstitial lung disease: a retrospective cohort study. [europepmc]
• The Role of the Multidisciplinary Evaluation of Interstitial Lung Diseases: Systematic Literature Review of the Current Evidence and Future Perspectives. [europepmc]
• Inflammatory Myopathy-Related Interstitial Lung Disease: From Pathophysiology to Treatment. [europepmc]
• Myositis-specific antibodies identify a distinct interstitial pneumonia with autoimmune features phenotype. [europepmc]
• Predictors and Mortality of Rapidly Progressive Interstitial Lung Disease in Patients With Idiopathic Inflammatory Myopathy: A Series of 474 Patients. [europepmc]
• Diagnosis and management of connective tissue disease-associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand. [europepmc]
• Management of Myositis-Associated Interstitial Lung Disease. [europepmc]
• Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Idiopathic Inflammatory Myopathies in Patients With Myositis-Specific Autoantibodies. [europepmc]
• Incidence, Prevalence, and Mortality of Dermatomyositis: A Population-Based Cohort Study. [europepmc]
• A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases. [europepmc]
• Idiopathic inflammatory myopathies. [europepmc]
• New Onset of Autoimmune Diseases Following COVID-19 Diagnosis. [europepmc]
• Autoantibody Markers of Increased Risk of Malignancy in Patients with Dermatomyositis. [europepmc]
• Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositis. [europepmc]
• Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases. [europepmc]
• Efficacy and safety of rituximab treatment in patients with idiopathic inflammatory myopathies: A systematic review and meta-analysis. [europepmc]